SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

KOPRAN

BSE: 524280 30 Sep 2025
Healthcare
₹ 174
Kopran Ltd., specializes in Pharmaceuticals within the Healthcare sector.

KOPRAN - Share Price & Details

Market Cap
₹839.0
High /Low
340.0 / 154.0
Stock P/E
24.0
Book Value
₹107.0
Dividend Yield
1.73
ROCE
9.75
ROE
₹7.64
Face Value
10.0
PEG Ratio
-1.69
EVEBITDA
₹13.2
Debt
148
CMP / FCF
-43.7
Debt to equity
₹0.29
NP Ann
38.6
High price all time
370.0
Piotroski score
₹3.0
Graham Number
132.0
No. Eq. Shares
4.82
Net CF
₹11.4
Net profit
34.9
Price to book value
1.62
Interest Coverage
₹5.86
Low price all time
6.0
Industry PE
33.0
Reserves
₹470
Free Cash Flow
₹-17.0

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
KOPRAN LTD.531.3235.18513.350.73839.024.0
ANUH PHARMA LTD.1898.6883.011864.791.6683118.0
WANBURY LTD.1635.32134.911631.843.9581118.9

Peer Comparison Chart


About KOPRAN

Kopran Ltd.,, with Security Code 524280, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Is Kopran Limited a Hybrid Growth Value Stock Worth Holding - Stock Buyback Updates & Rapid Capital Appreciation

(28 Sep 2025)
Is Kopran Limited a Hybrid Growth Value Stock Worth Holding ✌️【Market Insights】✌️ Our proprietary investment models identify breakout stocks...
Read more →

Is Kopran (NSE:KOPRAN) A Risky Investment?

(09 Sep 2025)
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment...
Read more →

Kopran Promoter Group's Shareholding Rises to 26.92% After Acquisition

(09 Sep 2025)
The Promoter Group of Kopran Limited has increased its collective shareholding to 26.92% following an acquisition of shares, according to a...
Read more →

Kopran Stock Gains as Promoters Sign Family Settlement

(03 Sep 2025)
Mumbai, September 2, 2025 – The shares of Kopran Limited (NSE: KOPRAN, BSE: 524280) rose 2% intraday and closed 1.07% higher than the...
Read more →

Kopran Stock Rises Intraday 2% as Promoters Sign Family Settlement Agreement​

(02 Sep 2025)
Mumbai, September 2, 2025 – The shares of Kopran Limited (NSE: KOPRAN, BSE: 524280) rose 2% intraday and closed 1.07% higher than the...
Read more →

Kopran Hits New Low Amid Ongoing Decline and Weak Financial Metrics

(28 Aug 2025)
Kopran, a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, continuing a downward trend.
Read more →